Mostrar el registro sencillo del ítem

Artículo

dc.contributor.advisor
dc.creatorMorales, Fátimaes
dc.creatorRamirez, A.es
dc.creatorMorata-Tarifa, C.es
dc.creatorNavarro, S.A.es
dc.creatorMarchal, J.A.es
dc.creatorCampos, J.M.es
dc.creatorConejo-Garcia, A.es
dc.date.accessioned2024-02-20T15:16:46Z
dc.date.available2024-02-20T15:16:46Z
dc.date.issued2017
dc.identifier.citationMorales, F., Ramirez, A., Morata-Tarifa, C., Navarro, S.A., Marchal, J.A., Campos, J.M. y Conejo-Garcia, A. (2017). Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells. Future Meidicinal Chemistry, 9 (3), 293-302. https://doi.org/10.4155/fmc-2016-0212.
dc.identifier.issn1756-8919es
dc.identifier.urihttps://hdl.handle.net/11441/155383
dc.description.abstractCancer is among the leading causes of death worldwide. Medical interest has focused on macrocyclic polyamines because of their properties as antitumor agents. Results/Methodology: We have designed and synthesized a series of 1,2-diaminocyclohexane derivatives with notable in vitro antiproliferative activities against the MCF-7, HCT-116 and A375 cancer cell lines. Cell cycle and apoptosis analyses were also carried out. Our results show that all the compounds are potent cytotoxic agents, especially against the A375 cell line. Conclusion: The selective activity of the macrocyclic derivative against A375, via apoptosis, supposes a great advantage for future therapeutic use. This exemplifies the potential of 1,2-diaminocyclohexane derivatives to qualify as lead structures for future anticancer drug development due to their easy syntheses and noteworthy bioactivity.es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherFuture SCIes
dc.relation.ispartofFuture Meidicinal Chemistry, 9 (3), 293-302.
dc.rightsAtribución 4.0 Internacional
dc.subjectApoptosises
dc.subjectBreast canceres
dc.subjectColon canceres
dc.subject1,2-diaminocyclohexaneses
dc.subjectMacrocyclees
dc.subjectMelanomaes
dc.titleAntitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cellses
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/acceptedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Medicina Preventiva y Salud Públicaes
dc.relation.projectIDPI10/00592es
dc.relation.projectIDPI10/02295es
dc.relation.publisherversionhttps://www.future-science.com/doi/10.4155/fmc-2016-0212es
dc.identifier.doi10.4155/fmc-2016-0212es
dc.journaltitleFuture Meidicinal Chemistryes
dc.publication.volumen9es
dc.publication.issue3es
dc.publication.initialPage293es
dc.publication.endPage302es
dc.contributor.funderInstituto Carlos IIIes

FicherosTamañoFormatoVerDescripción
Antitumoral...pdf764.9KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Este documento está protegido por los derechos de propiedad intelectual e industrial. Sin perjuicio de las exenciones legales existentes, queda prohibida su reproducción, distribución, comunicación pública o transformación sin la autorización del titular de los derechos, a menos que se indique lo contrario.